Gammaglobulins Level is Predictive Factor of Evolution in Sarcoidosis
Condition(s):SarcoidosisLast Updated:April 12, 2018Completed
Hide Studies Not Open or Pending
Condition(s):SarcoidosisLast Updated:April 12, 2018Completed
Condition(s):Primary Immunodeficiency Diseases (PID)Last Updated:May 19, 2021Completed
Condition(s):Mild Cognitive ImpairmentLast Updated:June 25, 2019Completed
Condition(s):Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIGLast Updated:June 29, 2021Completed
Condition(s):Autoimmune Autonomic Ganglionopathy (AAG)Last Updated:July 2, 2017Completed
Condition(s):Dermatomyositis; Inclusion Body Myositis; PolymyositisLast Updated:March 4, 2008Completed
Condition(s):Newly Diagnosed Immune Thrombocytopenia in Children, First Line TreatmentLast Updated:March 1, 2023Recruiting
Condition(s):Guillain-Barre SyndromeLast Updated:November 15, 2023Not yet recruiting
Condition(s):2019-nCoVLast Updated:February 7, 2020Unknown status
Condition(s):Chronic Inflammatory Demyelinating PolyneuropathyLast Updated:March 4, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.